Current and future burden of venous thrombosis: Not simply predictable

por Scheres, Luuk J. J., Lijfering, Willem M., Cannegieter, Suzanne C.
Publicado 2018

The relationship between DOAC levels and clinical outcomes: The measures tell the tale

por Toorop, Myrthe M. A., Lijfering, Willem M., Scheres, Luuk J. J.
Publicado 2020

Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome—What is the evidence?

por Hamulyák, Eva N., Scheres, Luuk J. J., Goddijn, Mariëtte, Middeldorp, Saskia
Publicado 2021

Sex‐specific aspects of venous thromboembolism: What is new and what is next?

por Scheres, Luuk J. J., van Hylckama Vlieg, Astrid, Cannegieter, Suzanne C.
Publicado 2022

Bloodcurdling movies and measures of coagulation: Fear Factor crossover trial

por Nemeth, Banne, Scheres, Luuk J J, Lijfering, Willem M, Rosendaal, Frits R
Publicado 2015

Sex matters: Practice 5P's when treating young women with venous thromboembolism

por Bistervels, Ingrid M., Scheres, Luuk J. J., Hamulyák, Eva N., Middeldorp, Saskia
Publicado 2019

Prognostic characteristics and body mass index in patients with pulmonary embolism: does size matter?

por Beenen, Ludo F.M., Scheres, Luuk J.J., Stoker, Jaap, Middeldorp, Saskia
Publicado 2020

Global impact of World Sepsis Day on digital awareness of sepsis: an evaluation using Google Trends

por Savelkoel, Jelmer, Claushuis, Theodora A. M., van Engelen, Tjitske S. R., Scheres, Luuk J. J., Wiersinga, W. Joost
Publicado 2018

Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials

por Scheres, Luuk J. J., Lijfering, Willem M., Middeldorp, Saskia, Cheung, Yuk W., Barco, Stefano, Cannegieter, Suzanne C., Coppens, Michiel
Publicado 2018

Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study

por Yap, Eng Soo, Lijfering, Willem M., Timp, Jasmijn F., Rosendaal, Frits R., Cannegieter, Suzanne C., Scheres, Luuk J. J.
Publicado 2023

Sex‐specific differences in clot resolution 3 weeks after acute pulmonary embolism managed with anticoagulants—A substudy of the EINSTEIN‐PE study

por Wiegers, Hanke M. G., van Es, Josien, Pap, Ákos F., Lensing, Anthonie W. A., Middeldorp, Saskia, Scheres, Luuk J. J.
Publicado 2021

Effect of gender‐affirming hormone use on coagulation profiles in transmen and transwomen

por Scheres, Luuk J.J., Selier, Nienke L.D., Nota, Nienke M., van Diemen, Jeske J.K., Cannegieter, Suzanne C., den Heijer, Martin
Publicado 2021

Hypertensive Complications of Pregnancy and Risk of Venous Thromboembolism

por Scheres, Luuk J.J., Lijfering, Willem M., Groenewegen, Norbert F.M., Koole, Sanne, de Groot, Christianne J.M., Middeldorp, Saskia, Cannegieter, Suzanne C.
Publicado 2020

Adults with osteogenesis imperfecta: Clinical characteristics of 151 patients with a focus on bisphosphonate use and bone density measurements

por Scheres, Luuk J.J., van Dijk, Fleur S., Harsevoort, Arjan J., van Dijk, Atty T.H., Dommisse, Anne Marieke, Janus, Guus J.M., Franken, Anton A.M.
Publicado 2018

Endogenous sex hormones and risk of venous thromboembolism in young women

por Scheres, Luuk J. J., van Hylckama Vlieg, Astrid, Ballieux, Bart E. P. B., Fauser, Bart C. J. M., Rosendaal, Frits R., Middeldorp, Saskia, Cannegieter, Suzanne C.
Publicado 2019

Clinical outcome of patients with a vitamin K antagonist‐associated bleeding treated with prothrombin complex concentrate

por Brekelmans, Marjolein P. A., Abdoellakhan, Rahat A., Scheres, Luuk J. J., Biedermann, Joseph S., Hutten, Barbara A., Meijer, Karina, Cate, Hugo ten, Huisman, Menno V., Kruip, Marieke J. H. A., Middeldorp, Saskia, Coppens, Michiel
Publicado 2017

Cardiovascular risk prediction models for women in the general population: A systematic review

por Baart, Sara J., Dam, Veerle, Scheres, Luuk J. J., Damen, Johanna A. A. G., Spijker, René, Schuit, Ewoud, Debray, Thomas P. A., Fauser, Bart C. J. M., Boersma, Eric, Moons, Karel G. M., van der Schouw, Yvonne T.
Publicado 2019

Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study

por Hamulyák, Eva N., Wiegers, Hanke M. G., Scheres, Luuk J. J., Hutten, Barbara A., de Lange, Maria E., Timmermans, Anne, Westerweel, Peter E., Nijziel, Marten R., Kruip, Marieke J. H. A., ten Wolde, Marije, Ypma, Paula F., Klok, Frederikus A., Nieuwenhuizen, Laurens, van Wissen, Sanne, Hovens, Marcel M. C., Faber, Laura M., Kamphuisen, Pieter W., Büller, Harry R., Middeldorp, Saskia
Publicado 2020